Rate of Ventricular Enlargement in Multiple Sclerosis: A Nine-Year Magnetic Resonance Imaging Follow-up Study

References

• Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006; 5: 158–70
   PubMed Web of Science ®Google Scholar
• Liu C, Edwards S, Gong Q, Roberts N, Blumhardt LD. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999; 66: 323–30
   PubMed Web of Science ®Google Scholar
• Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1999; 53: 139–48
   PubMed Web of Science ®Google Scholar
• Brex PA, Jenkins R, Fox NC, Crum WR, O'Riordan JI, Plant GT, et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 2000; 54: 1689–91
   PubMed Web of Science ®Google Scholar
• Bakshi R, Benedict RH, Bermel RA, Jacobs L. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings. J Neuroimaging 2001; 11: 129–36
   PubMed Web of Science ®Google Scholar
• Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. J Neuroimaging 2005; 15: 30–45
   PubMed Web of Science ®Google Scholar
• Fisher E, Rudick RA, Simon JH, Cutter G, Baier M, Lee JC, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002; 59: 1412–20
   PubMed Web of Science ®Google Scholar
• Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J Neuroimaging 2004; 14: 27–35
   PubMed Web of Science ®Google Scholar
• Fox NC, Jenkins R, Leary SM, Stevenson VL, Losseff NA, Crum WR, et al. Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 2000; 54: 807–12
   PubMed Web of Science ®Google Scholar
• Turner B, Lin X, Calmon G, Roberts N, Blumhardt LD. Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years. Mult Scler 2003; 9: 21–7
   PubMed Web of Science ®Google Scholar
• Dalton CM, Miszkiel KA, O′Connor PW, Plant GT, Rice GP, Miller DH. Ventricular enlargement in MS: one-year change at various stages of disease. Neurology 2006; 66: 693–8
   PubMed Web of Science ®Google Scholar
• Pagani E, Rocca MA, Gallo A, Rovaris M, Martinelli V, Comi G, et al. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. Am J Neuroradiol 2005; 26: 341–6
   PubMed Web of Science ®Google Scholar
• Eriksson M, Andersen O, Runmarker B. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2003; 9: 260–74
   PubMed Web of Science ®Google Scholar
• Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993; 116: 117–34
   PubMed Web of Science ®Google Scholar
• Bastos-Leite AJ, van der Flier WM, van Straaten EC, Staekenborg SS, Scheltens P, Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007; 38: 3182–5
   PubMed Web of Science ®Google Scholar
• Thompson PM, Hayashi KM, de Zubicaray G, Janke Al, Rose SE, Semple J, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003; 23: 994–1005
   PubMed Web of Science ®Google Scholar
• Mark VW, Taub E, Perkins C, Gauthier LV, Uswatte G, Ogorek J. Poststroke cerebral peduncular atrophy correlates with a measure of corticospinal tract injury in the cerebral hemisphere. Am J Neuroradiol 2008; 29: 354–8
   PubMed Web of Science ®Google Scholar
• Kassubek J, Juengling FD, Kioschies T, Henkel K, Karitzky J, Kramer B, et al. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004; 75: 213–20
   PubMed Web of Science ®Google Scholar
• Narr KL, Sharma T, Woods RP, Thompson PM, Sowell ER, Rex D, et al. Increases in regional subarachnoid CSF without apparent cortical gray matter deficits in schizophrenia: modulating effects of sex and age. Am J Psychiatry 2003; 160: 2169–80
   PubMed Web of Science ®Google Scholar
• Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003; 60: 989–94
   PubMed Web of Science ®Google Scholar
• Liu RS, Lemieux L, Bell GS, Sisodiya SM, Shorvon SD, Sander JW, et al. A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage 2003; 20: 22–33
   PubMed Web of Science ®Google Scholar
• Ge Y, Grossman RI, Babb JS, Rabin ML, Mannon LJ, Kolson DL. Age-related total gray matter and white matter changes in normal adult brain. Part I: volumetric MR imaging analysis. Am J Neuroradiol 2002; 23: 1327–33
   PubMed Web of Science ®Google Scholar
• Martola J, Stawiarz L, Fredrikson S, Hillert J, Bergström J, Flodmark O, et al. Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development. J Neurol Neurosurg Psychiatry 2007; 78: 375–80
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–52
   PubMed Web of Science ®Google Scholar
• Roxburgh RH, Seaman SR, Masterman T, Hensiek EA, Sawcer SJ, Vukusic S, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144–51
   PubMed Web of Science ®Google Scholar
• Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–31
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria. Ann Neurol 2005; 58: 840–6
   PubMed Web of Science ®Google Scholar
• Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. John Wiley & Sons, New Jersey 2004; 192–234
   Google Scholar
• Kalkers NF, Ameziane N, Bot JC, Minneboo A, Polman CH, Barkhof F. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch Neurol 2002; 59: 1572–6
   PubMedGoogle Scholar
• Ingle GT, Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, et al. Two-year follow-up study of primary and transitional progressive multiple sclerosis. Mult Scler 2002; 8: 108–14
   PubMed Web of Science ®Google Scholar
• Ingle GT, Stevenson VL, Miller DH, Thompson AJ. Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 2003; 126: 2528–36
   PubMed Web of Science ®Google Scholar
• Turner B, Ramli N, Blumhardt LD, Jaspan T. Ventricular enlargement in multiple sclerosis: a comparison of three-dimensional and linear MRI estimates. Neuroradiology 2001; 43: 608–14
   PubMed Web of Science ®Google Scholar
• Hobart J, Freeman J, Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000; 123: 1027–40
   PubMed Web of Science ®Google Scholar